CANbridge Pharmaceuticals Inc. (1228.HK) - Stock Prices, Stock Peers & Analysis

Home
1228.HK

Company Name	CANbridge Pharmaceuticals Inc.
Symbol	1228.HK
Currency	HKD
Price	0.265
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	112,582,155
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.187 - 1.6
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. James Qun Xue M.B.A., Ph.D.
Website	https://www.canbridgepharma.com

An error occurred while fetching data.

About CANbridge Pharmaceuticals Inc.

CANbridge Pharmaceuticals Inc., a biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare diseases and oncology indications worldwide. The company offers Hunterase, an enzyme replacement therapy for the treatment of Hunter syndrome; NERLYNX (Neratinlib), a potent irreversible tyrosine kinase inhibitor for HER2-positive breast cancer; and Caphosol